AI Enhanced Clinical Genomics Accelerating Discovery of Ultra Rare Disorders
The intersection of artificial intelligence (AI) and clinical genomics is transforming the landscape of medical research and patient care. As we delve into the world of AI-enhanced clinical genomics, we uncover its pivotal role in accelerating the discovery of ultra-rare disorders. Ultra-rare disorders, defined as conditions affecting fewer than 1 in 2,000 individuals, often go undiagnosed due to their infrequency and complex nature. The integration of AI technologies is not only streamlining diagnostic processes but also expediting the journey toward effective treatments.